Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.
What type of papers does Lung Cancer publish?
The Editors welcome submissions of original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer.
Why publish with Lung Cancer?
- Journal Impact Factor 5.3 (2022) and CiteScore 10.3 (2022)
- Rigorous peer review by noted experts in the field
ESMO members are entitled to receive a 20% discount on the journal's article publication charge for all papers submitted after January 1st 2023. Find out more about joining ESMO